Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon
Abstract Background Clostridioides difficile infection (CDI) has a high recurrent infection rate. Faecal microbiota transplantation (FMT) has been used successfully to treat recurrent CDI, but much remains unknown about the human gut microbiota response to replacement therapies. In this study, antib...
Main Authors: | Ines B. Moura, Charmaine Normington, Duncan Ewin, Emma Clark, Mark H. Wilcox, Anthony M. Buckley, Caroline H. Chilton |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | BMC Microbiology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12866-019-1669-2 |
Similar Items
-
Effect of Tulathromycin on colonization resistance, antimicrobial resistance and virulence of human gut microbiota in Chemostats
by: Haihong eHao, et al.
Published: (2016-04-01) -
Treating Clostridium difficile infections: Should fecal microbiota transplantation be reclassified from investigational drug to human tissue?
by: Mark Stuntz, et al.
Published: (2015-10-01) -
Dilution as a Solution: Targeting Microbial Populations with a Simplified Dilution Strategy
by: Disha Bhattacharjee, et al.
Published: (2020-07-01) -
The role of fecal microbiota transplantation in the therapy of intestinal and extraintestinal diseases: The basics for health professionals
by: Aleksandra Kwiatkowska, et al.
Published: (2019-06-01) -
Influence of diffusion and convection on the chemostat dynamics
by: Aleksei Vladimirovich Borisov, et al.
Published: (2012-03-01)